Home ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan

ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact

Español

Read time: 0 mins

https://rovi.es/sites/default/files/OIR%2029.08.2021_eng_0.pdf

Year:

2021

ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan

A) FORM FOR EXERCISE OF RIGHT OF ACCESS

Particulars of applicant:

He/she requests:

B) FORM FOR EXERCISE OF RIGHT TO RECTIFICATION

Particulars of applicant:

He/she requests:

C) FORM FOR EXERCISE OF THE RIGHT TO ERASURE

Particulars of applicant:

He/she requests:

Reasons for erasure:

D) FORM FOR EXERCISE OF THE RIGHT TO RESTRICTION OF PROCESSING

Particulars of applicant:

He/she requests:

E) FORM FOR EXERCISE OF THE RIGHT TO DATA PORTABILITY

Particulars of applicant:

He/she requests:

F) FORM FOR EXERCISE OF THE RIGHT TO OBJECT

Particulars of applicant:

He/she requests: